EW26 Poster Gallery
Self-Guided Tours:
> Monday, May 4, 5 – 7 PM
> Tuesday, May 5, 8 AM – 5 PM
> Wednesday, May 6, 8 AM – 3 PM
Poster Session + Meet the Authors:
> Tuesday, May 5, 9 AM – 9:30 AM
> Wednesday, May 6, 9 AM – 9:30 AM
Click on the poster titles below to view descriptions and author information.
|
Search / Filter
|
|
|
A Practical Risk-Based Framework for Assessing Microbiological Risk in Nonsterile Manufacturing Processes
Speaker(s): Jessica Chiaruttini, ValSource Inc.
|
|
001 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
AI-Driven subvisible particle classification in pharmaceutical excipients using FlowCam microscopy.
Speaker(s): Joanna Krise, Captisol
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Addressing Handling Challenges of Chemicals by Dry Granulation
Speaker(s): Lyndon Salins, MilliporeSigma
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Biosustane as a Novel Oral Excipient for Solid Dosage Forms-Formulation Development, Characterization, and IVIVC predictions
Speaker(s): Zia Uddin Masum, St. Johns University
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Driving Innovation Through Regulatory Evolution: Global Perspectives on Novel Excipients and New Approach Methodologies (NAMs)
Speaker(s): Teresa Wegesser, Amgen, Inc.
|
|
001 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Effect of Enteric Polymers on Delayed-Release, Dose-Flexible Matrix Tablets of a Tolfenamic acid
Speaker(s): Bhanu Prakash Dongala, Texas A&M University
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 03FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Enabling Robust Direct Compression of Amorphous Solid Dispersions using a Multifunctional Co-Processed Excipient
Speaker(s): Sateesh Kumar Vemula, University of Mississippi
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FAFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Evaluation of three topical permeation enhancers for lidocaine delivery using Franz cell permeation and MSI
Speaker(s): Yasaman Saleh, Croda
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Excipient-Driven Design of Pediatric SLS 3D-Printed Dosage Forms Using Polymers and Sweeteners
Speaker(s): Swaroop Jalandar Pansare, Texas A&M University
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
From Compliance to Quality Maturity: Strengthening Excipient Oversight Through Governance, Risk, and Performance Integration
Speaker(s): Gretchen McAuliffe, Labtopia Inc.
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FAFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Hot-Melt Extrusion Enabled Amorphous Solid Dispersions: A Comparative Study of Binary and Ternary Polymer Systems
Speaker(s): Srikanth Baisa, University of Mississippi
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Hydroxypropyl beta-cyclodextrin as a multifunctional excipient for downstream processing and formulation of monoclonal antibodies
Speaker(s): Lily Lin, Roquette Health & Pharma Solutions
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Impact of DMSO purity on cytotoxicity and cryopreservation outcomes across diverse cell types
Speaker(s): Natalie Aldor, Wilfrid Laurier University/ gChem
|
|
001 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Impact of Lactose Type on the Critical Quality Attributes of Digoxin Tablets
Speaker(s): Rizwan Shaikh, Texas A&M unversity
|
|
001 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 03FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Influence of POLYOX™ Molecular Weight and Concentration on Phenylephrine HCl Release from Hydrophilic Matrix
Speaker(s): Nasrin Mahmoudi, Roquette
|
|
001 |
13FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Influence of different HPMCAS grades on enteric capsule preparation investigated by MRI in human volunteers
Speaker(s): Josh Uyaan, Lonza
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Innovative Lipid-Based Delivery for Scalable Manufacturing of Genetically Modified Immune and Stem Cells
Speaker(s): Brooke Perez, Sartorius Stedim North America
|
|
001 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 03FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
ModulaSENSE® Bitter – a novel taste modulation technology to enhance drug palatability
Speaker(s): Carlos Almasqué, dsm-firmenich
|
|
001 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Orally Dissolving Films (ODFs): A Modern Solution for Convenient Drug Delivery
Speaker(s): Usha Chowdhury, Univar Solutions
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Pea Starch as an environmentally sustainable solution in pharmaceutical film coating applications using the ReadiLYCOAT®
Speaker(s): Samuel Robertkennedy Paulvia, Roquette Pharmaceutical Innovation Center; Spring House Innovation Park
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 FBFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 03FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Reduction of Agglomeration and Production Optimization for Enteric Pellet Coatings
Speaker(s): Mahmud Yunis, BIOGRUND US, Inc
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
Scientific Challenges in Developing Novel Excipients: Leveraging NAMs, AI, and Machine Learning to Overcome Barriers
Speaker(s): Teresa Wegesser, Amgen, Inc.
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
USP Compendial and Iterative Approaches to Address Diethylene Glycol and Ethylene Glycol Challenges
Speaker(s): Jenny Liu, US Pharmacopeia
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 21FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F7FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
USP’s Approach to Yellow Wax and White Wax Analysis: From Identification to Compositional Analysis
Speaker(s): Hong Wang, US Pharmacopeia
|
|
001 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 FAFEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 00FFB84B-B75D-F011-8104-ED7CCB3A2628 01FFB84B-B75D-F011-8104-ED7CCB3A2628 02FFB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
|
|
001 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 FEFEB84B-B75D-F011-8104-ED7CCB3A2628 FFFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
ZoomLab®-Enabled Design of Loratadine Tablets: Effects of Binder and Tooling on Dissolution and IVIVC
Speaker(s): Sravani Ravula, St. John's university
|
|
001 |
14FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 04FFB84B-B75D-F011-8104-ED7CCB3A2628 F4FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 FCFEB84B-B75D-F011-8104-ED7CCB3A2628 FDFEB84B-B75D-F011-8104-ED7CCB3A2628 |
||||
|
|
in vivo-jetPEI®, an Alternative to Lipid-Based Reagents or Viral Vectors for Nucleic Acid-Mediated Therapies
Speaker(s): Brooke Perez, Sartorius Stedim North America
|
|
001 |
15FFB84B-B75D-F011-8104-ED7CCB3A2628 11FFB84B-B75D-F011-8104-ED7CCB3A2628 07FFB84B-B75D-F011-8104-ED7CCB3A2628 20FFB84B-B75D-F011-8104-ED7CCB3A2628 05FFB84B-B75D-F011-8104-ED7CCB3A2628 F5FEB84B-B75D-F011-8104-ED7CCB3A2628 F6FEB84B-B75D-F011-8104-ED7CCB3A2628 F8FEB84B-B75D-F011-8104-ED7CCB3A2628 F9FEB84B-B75D-F011-8104-ED7CCB3A2628 03FFB84B-B75D-F011-8104-ED7CCB3A2628 |